Strategy Buys Another $472.5M in Bitcoin as BTC Surges to Record $118K
Michael Saylor’s Strategy has deepened its position in the flagship cryptocurrency, snapping up an additional 4,225 BTC last week for $472.5 million.
Michael Saylor’s Strategy has deepened its position in the flagship cryptocurrency, snapping up an additional 4,225 BTC last week for $472.5 million.
According to a filing with the US Securities and Exchange Commission on Monday, Strategy’s latest purchase was made at an average price of $111,827 per coin. The acquisition came as Bitcoin surged from around $108,000 early last week to reach a new historic high of $118,000 by Sunday, according to CoinGecko data. Prices continued to rise on Monday, reaching a high of $123,000.
ALT TXT: An excerpt from Strategy’s Form 8-K.
Source: SEC
The new purchase brings Strategy’s total Bitcoin holdings to a staggering 601,550 BTC, valued at approximately $42.87 billion, with its average cost basis now at $71,268 per coin.
This marks Strategy’s first officially disclosed Bitcoin purchase in July following a brief buying pause during the first week of the month. During that period, the company announced a $4.2 billion stock sale and reported $14 billion in unrealized gains for Q2 2025. A similar pause occurred in April as it prepared to report its Q1 financial results.
Year-to-date, Strategy has added 88,062 BTC to its treasury, worth roughly $10.9 billion, bringing it closer to last year’s total acquisition of 140,538 BTC valued at $13 billion.
As Bitcoin broke through previous highs above $112,000 midweek, Strategy co-founder and chairman Michael Saylor reaffirmed his long-term bullish stance. Quoting his famous 2021 interview with Unchained’s Laura Shin, he posted on X
In that original interview, Saylor argued Bitcoin remains a technically superior asset compared to traditional currencies, gold, and stock indices – a view he continues to champion as Strategy’s aggressive accumulation strategy reshapes corporate treasury standards worldwide.
Meanwhile, in May, Michael Saylor criticized the growing trend among institutions to publish onchain proof-of-reserves, warning that it introduces significant security vulnerabilities.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As AI controversies escalate, hedge funds buy tech stocks at the fastest pace in 15 months
Hedge funds have recorded net purchases of US TMT stocks on 10 out of the past 11 trading days, rebuilding tech long positions at the fastest pace in 15 months. However, an AI policy storm has struck at the "worst possible time"—calls by AI giants to slow down development have been rejected, and regulatory uncertainty has directly hit Asian tech stocks such as Softbank. As the tech sector's bullish run coincides with Super Central Bank Week, the sector now faces a severe test.
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
SUI holds $0.71 support as analysts cite key buy signal, eyes on possible recovery
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.

